The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Pharmaceutics Sabbatical Fellowship
Pharmaceutics is the science that deals with drug delivery systems—in particular, the design and evaluation of contemporary pharmaceutical dosage forms and systems to ensure their safety, efficacy, and reliability. It is a multidisciplinary discipline with significant underpinnings from basic sciences such as physical chemistry, physical organic chemistry, and biophysics.
Pharmaceutics strongly emphasizes quantitative understanding and use of the principles underlying drug delivery and drug transport, whether a drug is a small organic molecule, a higher molecular weight peptide, a protein derived through biotechnology, or an oligonucleotide-like molecule for gene therapy. It is also concerned with the impact of formulation composition and manufacturing/engineering factors on the quality of a dosage form and its physical and chemical stability.
As advances in genomics—the study of genes and their functions—result in identification and production of functional genes, a quantitative understanding of factors influencing gene therapy delivery will become an increasingly important component of pharmaceutics.
Deadline: Sep. 1, 2019
Eligible applicants must 1) hold a PhD, Pharm.D, MD or Sc.D degree in a field of study logically or functionally related to the proposed post doctoral activities, 2) hold a faculty appointment that presents eligibility for sabbatical leave from their institution, 3) have institutional approval of a sabbatical plan that includes partial salary matching the PhRMA Foundation stipend, and 4) have an endorsement from a mentor who agrees to sponsor the applicant’s visiting scientist activity. All applicants must be U.S. citizens or permanent residents.
- This fellowship primarily encourages mid-career scientists to engage in a year-long experiential program that will refocus their core research on areas of emerging importance in health outcomes.
Awards may be activated beginning January 1, 2019, or on the first day of any month thereafter, up to and including December 1, 2019.
A stipend of $40,000, payable quarterly for a minimum of six months and a maximum of one year, will be provided.
The program provides no other subsidies (travel, tuition, fringe benefits, indirect institutional costs, etc.).
The award will be made to the institution on behalf of the fellow.